Potomac Photonics wins Sub-contract Award in collaboration with UMBC & FDA to develop a microfluidic ‘on-the-spot’ bioburden detection device.
The Food and Drug Administration (FDA) awarded the University of Maryland Baltimore County (UMBC), Center for Advanced Sensor Technology (CAST), a 3-year grant for the commercialization of a microfluidic device for Rapid bioburden detection in pharmaceutical production. Potomac Photonics was selected as a sub-contractor to focus on the design, scale-up and manufacturing of the microfluidic bioburden detection cassettes.
Sterility, also referred to as bioburden contamination, is a big concern in biopharmaceutical manufacturing. The cost of contamination is tremendous, and preventing it requires strict control of the possible entry points. A single incident of contamination can result in loss of batch product, production time, and resources, including a complete shutdown of the facility.
Multi-layer microfluidic device.
Extensive quality assurance and quality control protocols are often what maintain the Good Manufacturing Practices and keep regular track of threats of bioburden in the pharmaceutical product. These protocols usually employ cell culture-based systems where a typical culture plating takes 24-72 hours, which may be inadequate for certain pharmaceutical products. If bioburden detection is prolonged, it can cause delays in production and/or closure of the facility, resulting in loss of ability to deliver product to patients as well as a loss of commercial revenue. There are many pharmaceuticals that inherently cannot be sterilized by the traditional methods, e.g. live viruses (vaccines), living cells (blood, blood components, cell therapies), viral vectors (gene therapies), biomolecules such as DNA (gene therapy), and proteins (vaccines and therapeutics). So, much slower analytical methods must be employed, making these pharmaceuticals an ideal target for applying a rapid detection method. Additionally, there are a number of important products with very short shelf life (e.g. radioactive products) that would strongly benefit from rapid methods for sterility. Our proposed project aims to commercialize a rapid on-the-spot microfluidic bioburden detection device capable of providing real-time bioburden data.
Potomac has significant experience in design and mass-production of microfluidic devices for biomedical applications. This effort will be led by the Potomac MicroFab Lab who, in concert with the Potomac’s Production Team, will help commercialize this technology for microbial bioburden detection and other Point-of-Care applications. Potomac Photonics Inc. specializes in various microfluidic device fabrication methods, with client services for feature sizes ranging from 2mm – 2mm, and provides a wide range of capabilities with high precision multiplexing options. Together with the UMBC and the FDA, Potomac Photonics will create cost-effective manufacturing solutions using thermoplastic devices, and provide a path towards seamless manufacturing.
Gurramkonda, C., Mupparapu, K., Abouzeid, R., Kostov, Y., Rao, G. (2013) Fluorescence-Based Method and a Device for Rapid Detection of Microbial Contamination. PDA J. Pharm. Sci. and Tech. 68, 164-171, doi: 5731/pdajpst.2014.00951
March 2020, Astek Diagnostics LLC, won the Maryland Innovation Initiative (MII) Award to develop a microfluidic device to detect bacterial infections in blood and evaluate the antimicrobial susceptibility. Astek, in partnership with Potomac Photonics Inc., will be designing a state-of-the art microfluidic lab-on-chip sensor for rapid detection of microorganisms in bodily fluids (like, blood, urine,…
We are seeing so many emails and blog posts from companies that say: “We Stand With Black Lives Matter Protesters”. But when all is said and done, how does a company move beyond rhetoric to action? Saying you support the Black Lives Matter movement is a far cry from hiring and training black people locally…
Quality assurance is at the heart of everything we manufacture at Potomac. It is our attention to product and process control that ensures every microfluidic device, consumer product, medical device and electronic component meets our customers’ rigid standards. Manufacturing Microfluidic technology in particular requires strong quality processes. In order to fabricate high performing microfluidic devices…